2/. A key benefit of bioencapsulation is its ability to release the active agent directly at the source of disease facilitating localised treatment thus increasing efficacy (as the treatment agent is delivered directly). The increased efficacy can also allow for lower dosages, thereby reducing side effects. The bioencapsulation technology also facilitates the treatment of systemic diseases (in the case of diseases such as diabetes).

1/. Surviving and being controlled like any other living cell in the body. As the cellulose sulphate is permeable, small molecules such as nutrients and oxygen can pass through its pores enabling the encapsulated therapeutic cells to ‘live’ in the body – thereby becoming de facto cells of the body;

3/. Evading the body’s immune system. ‘Foreign’ cells are not recognised by the immune system as they sit within a cellulose sulphate capsule (and immune cells are too large to pass through the capsule’s pores). Therefore the encapsulated cells are not rejected by the immune system, removing the need for immunosuppressive drugs as part of the patient’s treatment.